Vollins James
- SEC CIK
- 0001757833
No open-market purchases or sales filed in the past year.
Current role at each company
- EIGR Eiger BioPharmaceuticals, Inc.General Counselas of May 2, 2023
- BDSI Biodelivery Sciences International IncSee Remarksas of Mar 22, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Vollins James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BDSI Biodelivery Sciences International Inc
See Remarks1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2022 (view filing) | Feb 4 | 4 days | Vollins JamesSee Remarks | SSale | −18.5K | $3.60 | −$66.7K | −65.3%9.87K after |